A comprehensive analysis of AI and ML clinical trials conducted between 2010 and 2023 has been published, examining 3106 studies. The findings indicate that 56.2% of these trials were randomized, with 44.2% sponsored by hospitals or clinics. Neoplasms were the focus of 12.9% of the studies, and a significant majority, 75.3%, were conducted in high-income countries. AI
IMPACT Provides insights into the application and trends of AI/ML in medical research, highlighting areas of focus and sponsorship.
RANK_REASON The item details the findings of a published analysis of AI/ML clinical trials, which constitutes research. [lever_c_demoted from research: ic=1 ai=0.7]
Read on Mastodon — sigmoid.social →
- 2010-2023
- 3106 studies
- clinical trial
- Hospital/clinical ethics committees' notion: an overview
- neoplasm
- randomized controlled trial
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
